Development of left ventricular diastolic dysfunction in children who are in long-term remission of acute lymphoblastic leukemia

Cover Page

Cite item

Full Text

Abstract

Aim. To determine the frequency and nature of myocardial damage in children on the background of long-term remission of acute lymphoblastic leukemia, to assess the significance of the concentration of the N-terminal precursor of the brain natriuretic peptide and of the protein that binds fatty acids in blood serum. Methods. The observation group included 22 children aged 7 to 17 years, who are in long-term remission of acute lymphoblastic leukemia. The average duration of the remission was 6.1±1.0 years. All children were treated according to the standard and intermediate risk group protocol ALL-MB-2002. The control group included 65 children. A clinical and instrumental examination, including 12-lead electrocardiography, as well as complex transthoracic Doppler echocardiography was conducted. Analysis of the diastolic function of the myocardium was performed during assessment of the ratio of peak transmitral flow velocities (E/A), of the index of myocardial stiffness and of the time indicator B(E-Ea). The content of the N-terminal precursor of the brain natriuretic peptide and of the protein that binds fatty acids in blood serum was determined by enzyme immunoassay. Results. In 70% of the children with acute lymphoblastic leukemia who are in the remission stage for over 5 years, noted was the development of early signs of diastolic myocardial dysfunction, in 50% of the patients of this group reported was a significant increase in the concentration of the marker of heart failure - brain natriuretic peptide. At the same time, in a third of the examined individuals an increase in concentration of the protein that binds fatty acids was revealed, which may be indicative of myocardial damage at the cellular level. Positive correlation links between the indicators of initial manifestations of the evolving left ventricular diastolic dysfunction in children, who are in long-term remission of acute lymphoblastic leukemia, and the content of the N-terminal precursor of the brain natriuretic peptide have been revealed. Conclusion. The increase in the levels of the mentioned indicators makes it possible to identify high-risk groups for cardiovascular disease development among the cohort of children who are in long-term remission of acute lymphoblastic leukemia in order to develop preventive and rehabilitative programs.

About the authors

E D Teplyakova

Rostov State Medical University, Rostov-on-Don, Russia

Email: elenatepl@rambler.ru

A A Savis’ko

Rostov State Medical University, Rostov-on-Don, Russia

A V Shestopalov

Rostov State Medical University, Rostov-on-Don, Russia

K S Aslanyan

Regional Children’s Hospital, Rostov-on-Don, Russia

References

  1. Андреев Д.А. Натрийуретические пептиды В-типа при сердечной недостаточности: оценка прогноза и эффективности лечения // Лабор. мед. - 2003. - №6. - С. 42-47.
  2. Дедкова А.А., Суслова Т.Е., Кологривова И.В. и др. Факторы воспаления и маркёры повреждения миокарда при фибрилляции предсердий // Вестн. аритмолог. - 2010. - №60. - С. 49-53.
  3. Карачунский А.И., Румянцева Ю.В., Румянцев А.Г. Эволюция лечения острого лимфобластного лейкоза у детей: критическое использование мирового опыта в России // Вопросы гематол., онкол. и иммунопатол. в педиатр. - 2011. - Т. 10, №2. - С. 15-31.
  4. Мазур Н.А. Диастолическая дисфункция миокарда. - М.: Dr. Reddy’s, 2001. - 72 с.
  5. Румянцев А.Г. Основные достижения клинической онкологии в 2007 г. // Вопр. гематол. онкол. и иммунопатол. в педиатр. - 2008. - Т. 7, №44. - С. 7-10.
  6. Сависько А.А., Неласов Н.Ю., Теплякова Е.Д. и др. Применение нового допплерографического временного показателя для выявления начальных проявлений диастолической дисфункции левого желудочка у детей с острым лимфобластным лейкозом // Онкогематология. - 2011. - №2. - С. 50.
  7. Сависько А.А., Поморцев А.В., Неласов Н.Ю. и др. Разработка новой допплерографической методики выявления минимальных проявлений диастолической дисфункции левого желудочка у детей с острым лимфобластным лейкозом на этапах полихимиотерапии // Кубан. науч. мед. вестн. - 2011. - №2. - С. 140-145.
  8. Теплякова Е.Д., Тарасова Н.Е., Пармон С.П. и др. Оценка диастолической функции миокарда и кислородтранспортной функции крови у детей с острыми лимфобластными лейкозами на этапах проведения полихимиотерапии // Вестн. Волгоград. гос. мед. универ. - 2011. - №3. - С. 66-69.
  9. Щербатюк О.В., Тырсенко В.В., Белевитин А.Б. и др. Мозговой натрийуретический пептид - генетический код сердечной недостаточности // Вестн. рос. военно-мед. академ. - 2007. - №1. - С. 95-99.
  10. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects // Cardiovasc. Ultrasound. - 2005. - Vol. 3. - P. 9.
  11. Moe G.W. B-type natriuretic peptide in heart failure // Curr. Opin. Cardiol. - 2006. - Vol. 21, N 3. - Р. 208-214.
  12. Weber M., Hamm C. Role of B:type natriuretic peptide (BNP) and NT:proBNP in clinical routine // Heart. - 2006. - Vol. 92. - Р. 843-849.

© 2012 Teplyakova E.D., Savis’ko A.A., Shestopalov A.V., Aslanyan K.S.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies